North America Biopharmaceutical Tubing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Plastic, Metal, and Silicone) and Application (Pharmaceutical, Medical Devices, Research and Development, and Others)

The silicone segment by type is estimated to lead the market growth during the forecast period.

According to a new market research study of “North America Biopharmaceutical Tubing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type, Application and Country.” The North America biopharmaceutical tubing market is expected to reach US$ 3,090.82 million by 2028 from US$ 1,803.70 million in 2021; it is estimated to grow at a CAGR of 8% from 2021 to 2028. The report highlights trends prevailing in the North America biopharmaceutical tubing market and the factors driving market along with those that act as hindrances.

Increase in life expectancy is leading to rise in geriatric population in the world. This rise in elderly population has led to an increase in the geriatric ailments, thus generating a greater demand for diagnostic equipment and drug delivery systems. It is also increasing the incidence of urological conditions that require catheterization. Medical professionals are also encouraging self-catheterization to reduce the cost and period of hospitalization as well as to avert the risk of healthcare-associated infections (HAI). Aging is also a main factor that contributes to the increase in chronic diseases that might lead to the need for interventions that require admission to ICUs. Thus, rapid growth in the geriatric population is directly proportional to the rising demand for medical devices that incorporate tubing, drug delivery, dialysis and cardiac bypass, peristaltic pump, and sterile filling and dispensing systems, thereby driving the adoption of biopharmaceutical tubing systems. Also, popularity of minimally invasive surgical procedures has increased in the recent years owing to the benefits such as tiny incisions, faster recovery of patients, and less discomfort caused to the patients. The growing prevalence of arthritis, cancer, and cardiovascular diseases, all of which require extensive surgical treatments, has boosted the demand for minimally invasive procedures. As a result, there is an enormous demand for catheters and biopharmaceutical tubing, among other components. Further, biopharmaceutical tubing systems are reasonably priced and aid in time-saving procedures. For example, employing catheter tubing for cardiac and urine catheterization significantly lowers the time required for the medical or surgical operation. Therefore, the growing demand for minimally invasive medical procedures and focus on increasing the efficiency of these procedures play an important role in propelling the demand for biopharmaceutical tubing.

The North American region is highly affected due to the outbreak of the COVID-19 pandemic. The market players in North America are taking initiatives to combat the pandemic. For instance, Saint-Gobain Life Sciences, a US-based biopharmaceutical tubing company, identified the products that can fight against COVID-19 and have given them a priority. The company placed priority on delivering orders for COVID-19 products, including single-use assemblies for the development of new vaccines and therapies as well as components for life-saving medical devices, such as ventilators and infusion pumps; thus, there is rising demand for medical devices that incorporate tubing. Therefore, the growing demand for medical devices that incorporate tubing in North America is likely to boost the growth of the biopharmaceutical tubing market.

The North America biopharmaceutical tubing market, by type, is segmented into plastic, metal, and silicone. Based on application, the North America biopharmaceutical tubing market is segmented into pharmaceutical, medical devices, research and development, and others. Geographically, the North America biopharmaceutical tubing market can be bifurcated into U.S, Canada and Mexico.

W. L. Gore and Associates, Inc. Saint-Gobain Sekurit, Freudenberg Group, RAUMEDIC AG, TEKNI-PLEX, NewAge Industries, Inc, Optinova, Zeus Industrial Products, Inc. NORDSON CORPORATION and DuPont de Nemours, Inc. are among the leading companies operating in the North America biopharmaceutical tubing market

Reasons to buy:

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America biopharmaceutical tubing market
• Highlights key business priorities in order to assist companies to realign their business strategies
• The key findings and recommendations highlight crucial progressive industry trends in the North America biopharmaceutical tubing market, thereby allowing players across the value chain to develop effective long-term strategies
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
• Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.